Microfluidics Market

Global Microfluidics Market by Types (Polymer, Glass, Silica Gel, and Others), By Application (In-Vitro Diagnostic, Pharmaceuticals, Drug Delivery, and Others), By Technology (Medical/Healthcare {PCR & RT-PCR, Gel Electrophoresis, Microarrays, ELISA, and Others} and Non-Medical), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

  • Report ID: HC-2595
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 285
  • Format:
  • Pub. Date: 16-09-2021
  • Share:

Market Outlook:

The global microfluidics market was valued at USD 17,888.63 Mn in 2020 and is projected to reach USD 46,758.49 Mn by 2028, expanding at a CAGR of 12.76% during the forecast period. Growing number of clinical trials for cell-based therapeutics is driving the industry. Increasing demand for high-throughput screening approaches, low-volume sample analysis, In-vitro Diagnostics (IVD), and the development of innovative lab-on-a-chip technologies are all driving the market.

Microfluidics Market Key Takeaways

Market Dynamics

Growing technological breakthroughs in diagnostic devices, expanding demand for microfluidics technology, and rising incidence of chronic diseases are driving the microfluidics market. There have been significant technological breakthroughs in the contemporary market. Microfluidics advancements are enabling the creation of a cost-effective diagnostic device mass-production method, and cellphones linked with microfluidics are enabling the deployment of point-of-care testing. This broadened the scope of microfluidic device applications, which is projected to continue in the future.

In the following years, the global market for point-of-care diagnostics is estimated to expand at a growth rate of 10%. Rising prevalence of lifestyle-related and infectious diseases, as well as the growing preference for home healthcare, are driving the market. In addition, rising private investment and venture capital funding for the development of new products, as well as government support for enhancing PoC device usage, are boosting the PoC diagnostics industry. According to the World Health Organization (WHO), 95 million persons in poor and middle-income countries underwent HIV testing in 2010. Use of microfluidics in HIV testing at point-of-care (POCs) is projected to reduce costs and increase the demand for microfluidics.
Growing incidence of chronic diseases, availability of insurance coverage for laboratory testing procedures, adequate reimbursements for medical devices, and the presence of well-structured distribution channels in the region are driving the microfluidics market in various regions. Rising demand for self-administration and home healthcare devices, as well as increased applications of micro-pumps, inhalers, and transdermal microneedles for chronic illnesses such as migraine, diabetes, cancer pain, and asthma, promote the growth of the market.

Medical device manufacturers are required to adhere to strict regulatory standards in order to advertise and sell their goods in international markets. Key global players are situated in the US, hence it is a key manufacturing hub for microfluidic devices. The FDA established strict regulatory criteria and guidelines to ensure the safety and efficacy of medical devices in the US. The FDA clearance procedure for medical devices became a lengthy and difficult process in recent years. Companies face many difficulties while launching innovative products in the US. Any government enforcement action generates unfavorable publicity, which has a detrimental influence on the market.

Usage of bubbles as a substitute for mixers in microfluidics devices to solve challenges associated with device fabrication is expected to contribute to market expansion. There are two types of traditional microfluidic mixers: passive and active. Active mixers are controlled externally, while passive mixers transport fluids in or out of plane by leveraging the geometry of the system to induce chaotic advection of the fluids. Both have fabrication challenges, with passive mixers requiring two layers of fabrication and active mixers requiring additional and complex micro fabrication. When mixed with bubbles, no further construction is required, allowing for quick and efficient mixing.

Segment Outlook

By Type

Based on types, the global microfluidics market is segmented into polymer, glass, silica gel, and others. The glass segment is expected to hold a substantial share of the market during the forecast period, due to favourable reimbursement policies. Rapid growth in foreign investments is estimated to propel the segment.

Microfluidics Market By Type

By Application

Based on applications, the global microfluidics market is segmented into in-vitro diagnostic, pharmaceuticals, drug delivery, and others. The pharmaceutical segment is projected to expand at a significant CAGR during the forecast period, due to rising R&D spending in pharmaceuticals and life sciences, as well as rising demand for point-of-care diagnostics.

Microfluidics Market By Application

By Technology

Based on technology, the global microfluidics market is segmented into medical/healthcare and non-medical. The medical/healthcare segment is further bifurcated into PCR & RT-PCR, gel electrophoresis, microarrays, ELISA, and others. Microfluidics has non-medical applications such as extracting crude oil from porous rocks, detecting plant diseases, and creating different-sized gas bubbles. Optical analysis of fluid flow via porous media is difficult and complex.

Microfluidics Market By Technology

By Region

Based on regions, the global microfluidics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in countries such as the US and Canada is expected to grow at a rapid pace. Research institutes are playing an increasingly important role in the creation of new microfluidic devices, ensuring regional dominance in the global market. Throughout the research period, the US emerged as a crucial contributor to the dominance of the region in the global market.

Microfluidics Market By Regions

Key Benefits for Industry Participants & Stakeholders

  1. In-Depth Analysis of the Microfluidics Market.
  2. Historical, Current and Projected Market Size in Terms of Value.
  3. Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
  4. Industry Drivers, Restraints and Opportunities Covered in the Study
  5. Recent Industry Trends and Developments
  6. Competitive Landscape & Strategies of Key Players
  7. Neutral Perspective on From Microfluidics Market Performance

Segments

Key Segments Covered
By Type
  • Polymer
  • Glass
  • Silica Gel
  • Others
By Application
  • In-Vitro Diagnostic
  • Pharmaceuticals
  • Drug Delivery
  • Others
By Technology
  • Medical/Healthcare
  • PCR & RT-PCR
  • Gel Electrophoresis
  • Microarrays
  • ELISA
  • Others
  • Non-Medical
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Market Players Profiled in the Report
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cellix Ltd
  • Dolomite Microfluidics
  • Elveflow
  • Fluidigm Corporation
  • Fluigent
  • Hesperos, Inc.
  • Illumina, Inc.
  • microLIQUID
  • Micronit GmbH
  • MICRUX Technologies
  • PerkinElmer, Inc.
  • QIAGEN
  • Sphere Fluidics Limited
  • Thermo Fisher Scientific Inc.
  • uFluidix
  • BD
  • bioMérieux SA

Competitive Landscape

Key players in the microfluidics market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Cellix Ltd, Dolomite Microfluidics, Elveflow, Fluidigm Corporation, Fluigent, Hesperos, Inc., Illumina, Inc., microLIQUID, Micronit GmbH, MICRUX Technologies, PerkinElmer, Inc., QIAGEN, Sphere Fluidics Limited, Thermo Fisher Scientific Inc., uFluidix, BD, and bioMérieux SA.'

The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition, and many other strategies to cater the increasing demand for microfluidics system. For instance, in June 2021, Sphere Fluidics Limited partnered with ClexBio to introduce CYTRIX Microfluidic Hydrogel Kit with features such as 3D view of cell structure along with efficient encapsulation.

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microfluidics Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Microfluidics Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Microfluidics Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Microfluidics Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Microfluidics Market Size & Forecast, 2018-2028
      4.5.1 Microfluidics Market Size and Y-o-Y Growth
      4.5.2 Microfluidics Market Absolute $ Opportunity
Chapter 5 Global Microfluidics Market Analysis and Forecast By Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Type
      5.1.2 Basis Point Share (BPS) Analysis By Type
      5.1.3 Absolute $ Opportunity Assessment By Type
   5.2 Microfluidics Market Size Forecast By Type
      5.2.1 Polymer
      5.2.2 Glass
      5.2.3 Silica Gel
      5.2.4 Others
   5.3 Market Attractiveness Analysis By Type
Chapter 6 Global Microfluidics Market Analysis and Forecast By Application
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Application
      6.1.2 Basis Point Share (BPS) Analysis By Application
      6.1.3 Absolute $ Opportunity Assessment By Application
   6.2 Microfluidics Market Size Forecast By Application
      6.2.1 In-Vitro Diagnostic
      6.2.2 Pharmaceuticals
      6.2.3 Drug Delivery
      6.2.4 Others
   6.3 Market Attractiveness Analysis By Application
Chapter 7 Global Microfluidics Market Analysis and Forecast By Technology
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Technology
      7.1.2 Basis Point Share (BPS) Analysis By Technology
      7.1.3 Absolute $ Opportunity Assessment By Technology
   7.2 Microfluidics Market Size Forecast By Technology
      7.2.1 Medical/Healthcare
         7.2.1.1 PCR & RT-PCR
         7.2.1.2 Gel Electrophoresis
         7.2.1.3 Microarrays
         7.2.1.4 ELISA
         7.2.1.5 Others
      7.2.2 Non-Medical
   7.3 Market Attractiveness Analysis By Technology
Chapter 8 Global Microfluidics Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 Microfluidics Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America Microfluidics Analysis and Forecast
   10.1 Introduction
   10.2 North America Microfluidics Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America Microfluidics Market Size Forecast By Type
      10.6.1 Polymer
      10.6.2 Glass
      10.6.3 Silica Gel
      10.6.4 Others
   10.7 Basis Point Share (BPS) Analysis By Type
   10.8 Absolute $ Opportunity Assessment By Type
   10.9 Market Attractiveness Analysis By Type
   10.10 North America Microfluidics Market Size Forecast By Application
      10.10.1 In-Vitro Diagnostic
      10.10.2 Pharmaceuticals
      10.10.3 Drug Delivery
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis By Application
   10.12 Absolute $ Opportunity Assessment By Application
   10.13 Market Attractiveness Analysis By Application
   10.14 North America Microfluidics Market Size Forecast By Technology
      10.14.1 Medical/Healthcare
         10.14.1.1 PCR & RT-PCR
         10.14.1.2 Gel Electrophoresis
         10.14.1.3 Microarrays
         10.14.1.4 ELISA
         10.14.1.5 Others
      10.14.2 Non-Medical
   10.15 Basis Point Share (BPS) Analysis By Technology
   10.16 Absolute $ Opportunity Assessment By Technology
   10.17 Market Attractiveness Analysis By Technology
Chapter 11 Europe Microfluidics Analysis and Forecast
   11.1 Introduction
   11.2 Europe Microfluidics Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe Microfluidics Market Size Forecast By Type
      11.6.1 Polymer
      11.6.2 Glass
      11.6.3 Silica Gel
      11.6.4 Others
   11.7 Basis Point Share (BPS) Analysis By Type
   11.8 Absolute $ Opportunity Assessment By Type
   11.9 Market Attractiveness Analysis By Type
   11.10 Europe Microfluidics Market Size Forecast By Application
      11.10.1 In-Vitro Diagnostic
      11.10.2 Pharmaceuticals
      11.10.3 Drug Delivery
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis By Application
   11.12 Absolute $ Opportunity Assessment By Application
   11.13 Market Attractiveness Analysis By Application
   11.14 Europe Microfluidics Market Size Forecast By Technology
      11.14.1 Medical/Healthcare
         11.14.1.1 PCR & RT-PCR
         11.14.1.2 Gel Electrophoresis
         11.14.1.3 Microarrays
         11.14.1.4 ELISA
         11.14.1.5 Others
      11.14.2 Non-Medical
   11.15 Basis Point Share (BPS) Analysis By Technology
   11.16 Absolute $ Opportunity Assessment By Technology
   11.17 Market Attractiveness Analysis By Technology
Chapter 12 Asia Pacific Microfluidics Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific Microfluidics Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific Microfluidics Market Size Forecast By Type
      12.6.1 Polymer
      12.6.2 Glass
      12.6.3 Silica Gel
      12.6.4 Others
   12.7 Basis Point Share (BPS) Analysis By Type
   12.8 Absolute $ Opportunity Assessment By Type
   12.9 Market Attractiveness Analysis By Type
   12.10 Asia Pacific Microfluidics Market Size Forecast By Application
      12.10.1 In-Vitro Diagnostic
      12.10.2 Pharmaceuticals
      12.10.3 Drug Delivery
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis By Application
   12.12 Absolute $ Opportunity Assessment By Application
   12.13 Market Attractiveness Analysis By Application
   12.14 Asia Pacific Microfluidics Market Size Forecast By Technology
      12.14.1 Medical/Healthcare
         12.14.1.1 PCR & RT-PCR
         12.14.1.2 Gel Electrophoresis
         12.14.1.3 Microarrays
         12.14.1.4 ELISA
         12.14.1.5 Others
      12.14.2 Non-Medical
   12.15 Basis Point Share (BPS) Analysis By Technology
   12.16 Absolute $ Opportunity Assessment By Technology
   12.17 Market Attractiveness Analysis By Technology
Chapter 13 Latin America Microfluidics Analysis and Forecast
   13.1 Introduction
   13.2 Latin America Microfluidics Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America Microfluidics Market Size Forecast By Type
      13.6.1 Polymer
      13.6.2 Glass
      13.6.3 Silica Gel
      13.6.4 Others
   13.7 Basis Point Share (BPS) Analysis By Type
   13.8 Absolute $ Opportunity Assessment By Type
   13.9 Market Attractiveness Analysis By Type
   13.10 Latin America Microfluidics Market Size Forecast By Application
      13.10.1 In-Vitro Diagnostic
      13.10.2 Pharmaceuticals
      13.10.3 Drug Delivery
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis By Application
   13.12 Absolute $ Opportunity Assessment By Application
   13.13 Market Attractiveness Analysis By Application
   13.14 Latin America Microfluidics Market Size Forecast By Technology
      13.14.1 Medical/Healthcare
         13.14.1.1 PCR & RT-PCR
         13.14.1.2 Gel Electrophoresis
         13.14.1.3 Microarrays
         13.14.1.4 ELISA
         13.14.1.5 Others
      13.14.2 Non-Medical
   13.15 Basis Point Share (BPS) Analysis By Technology
   13.16 Absolute $ Opportunity Assessment By Technology
   13.17 Market Attractiveness Analysis By Technology
Chapter 14 Middle East & Africa (MEA) Microfluidics Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) Microfluidics Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) Microfluidics Market Size Forecast By Type
      14.6.1 Polymer
      14.6.2 Glass
      14.6.3 Silica Gel
      14.6.4 Others
   14.7 Basis Point Share (BPS) Analysis By Type
   14.8 Absolute $ Opportunity Assessment By Type
   14.9 Market Attractiveness Analysis By Type
   14.10 Middle East & Africa (MEA) Microfluidics Market Size Forecast By Application
      14.10.1 In-Vitro Diagnostic
      14.10.2 Pharmaceuticals
      14.10.3 Drug Delivery
      14.10.4 Others
   14.11 Basis Point Share (BPS) Analysis By Application
   14.12 Absolute $ Opportunity Assessment By Application
   14.13 Market Attractiveness Analysis By Application
   14.14 Middle East & Africa (MEA) Microfluidics Market Size Forecast By Technology
      14.14.1 Medical/Healthcare
         14.14.1.1 PCR & RT-PCR
         14.14.1.2 Gel Electrophoresis
         14.14.1.3 Microarrays
         14.14.1.4 ELISA
         14.14.1.5 Others
      14.14.2 Non-Medical
   14.15 Basis Point Share (BPS) Analysis By Technology
   14.16 Absolute $ Opportunity Assessment By Technology
   14.17 Market Attractiveness Analysis By Technology
Chapter 15 Competition Landscape
   15.1 Microfluidics Market: Competitive Dashboard
   15.2 Global Microfluidics Market: Market Share Analysis, 2020
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1 Agilent Technologies, Inc.
      15.3.2 Bio-Rad Laboratories, Inc.
      15.3.3 Cellix Ltd
      15.3.4 Dolomite Microfluidics
      15.3.5 Elveflow
      15.3.6 Fluigent
      15.3.7 Illumina, Inc.
      15.3.8 microLIQUID
      15.3.9 Micronit GmbH
      15.3.10 MICRUX Technologies
      15.3.11 PerkinElmer, Inc.
      15.3.12 QIAGEN
      15.3.13 Sphere Fluidics Limited
      15.3.14 Thermo Fisher Scientific Inc.
      15.3.15 uFluidix
      15.3.16 BD
      15.3.17 bioMérieux SA
      15.3.18 Hesperos, Inc.
      15.3.19 Fluidigm Corporation
Key Segments Covered
By Type
  • Polymer
  • Glass
  • Silica Gel
  • Others
By Application
  • In-Vitro Diagnostic
  • Pharmaceuticals
  • Drug Delivery
  • Others
By Technology
  • Medical/Healthcare
  • PCR & RT-PCR
  • Gel Electrophoresis
  • Microarrays
  • ELISA
  • Others
  • Non-Medical
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Market Players Profiled in the Report
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cellix Ltd
  • Dolomite Microfluidics
  • Elveflow
  • Fluidigm Corporation
  • Fluigent
  • Hesperos, Inc.
  • Illumina, Inc.
  • microLIQUID
  • Micronit GmbH
  • MICRUX Technologies
  • PerkinElmer, Inc.
  • QIAGEN
  • Sphere Fluidics Limited
  • Thermo Fisher Scientific Inc.
  • uFluidix
  • BD
  • bioMérieux SA

Key players in the microfluidics market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Cellix Ltd, Dolomite Microfluidics, Elveflow, Fluidigm Corporation, Fluigent, Hesperos, Inc., Illumina, Inc., microLIQUID, Micronit GmbH, MICRUX Technologies, PerkinElmer, Inc., QIAGEN, Sphere Fluidics Limited, Thermo Fisher Scientific Inc., uFluidix, BD, and bioMérieux SA.'

The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition, and many other strategies to cater the increasing demand for microfluidics system. For instance, in June 2021, Sphere Fluidics Limited partnered with ClexBio to introduce CYTRIX Microfluidic Hydrogel Kit with features such as 3D view of cell structure along with efficient encapsulation.

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles can be provided on request.

Microfluidic technologies provide for fast analysis, less reagent use, and accurate test results, all of which assist to lower the overall cost of drug development. In addition to these causes, the growing need and adoption of point-of-care diagnostic equipment, such as glucose monitoring and pregnancy test kits, is driving the demand for microfluidics technology.

According to this Growth Market Reports, the market from microfluidics market is likely to register a CAGR of 12.76% during period 2021-2028, with an anticipated valuation of USD 46,758.49 million by the end of the 2028.

In addition to market size (in USD Million) and Company Market Share (in % for base year 2020), other data such Macro-economic factors, COVID-19 Impact on the microfluidics market is available in final report.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

A major factor driving the microfluidics market is the growing technological breakthroughs in diagnostic devices, expanding demand for microfluidics technology, and rising incidence of chronic diseases are driving the microfluidics market.

The medical technology segment is anticipated to hold a significant share of the market during the forecast period, owing to the growing prevalence of chronic diseases.

The market is expected to witness decreased in terms of demand during 2019-2020 owing to the positive impact of COVID-19 pandemic on the microfluidics market.

The base year considered for the Microfluidics market report is 2020. The complete analysis period is 2018 to 2028, wherein, 2018 & 2019 are the historic years, and the forecast is provided from 2021 to 2028.

Major Manufactures include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Cellix Ltd, Dolomite Microfluidics, Elveflow, Fluidigm Corporation, Fluigent, Hesperos, Inc., Illumina, Inc., microLIQUID, Micronit GmbH, MICRUX Technologies, PerkinElmer, Inc., QIAGEN, Sphere Fluidics Limited, Thermo Fisher Scientific Inc., uFluidix, BD, and bioMérieux SA.